MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BERGSTRAND, H.
Right arrow Articles by SCHURMANN, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BERGSTRAND, H.
Right arrow Articles by SCHURMANN, A.

Molecular Pharmacology, Vol 13, 38-43, Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics

Effects of Antiallergic Agents, Compound 48/80, and Some Reference Inhibitors on the Activity of Partially Purified Human Lung Tissue Adenosine Cyclic 3',5'-Monophosphate and Guanosine Cyclic 3',5'-Monophosphate Phosphodiesterases

HAKAN BERGSTRAND 1, JAN KRISTOFFERSSON 1, BRITTA LUNDQUIST 1, and ANNIKA SCHURMANN 1

1 Research and Development Laboratories, AB Draco, Fack, S-221 01 Lund, Sweden

Various compounds, some of which influence immediate allergic reactions in different ways, were examined for inhibitory effects on partially purified human lung tissue cyclic nucleotide phosphodiesterases. Some of the compounds reported to possess antiallergic properties were found to be more potent as inhibitors of a low-Km, cyclic 3',5'-GMP-specific phosphodiesterase than of a corresponding low-Km, cyclic 3',5'-AMP-specific enzyme. For 2-o-propoxyphenyl-8-azapurin-6-one (M & B 22,948), 6-n-butyl-2,8-dicarboxy-4,10-dioxo-1,4,7,10-tetrahydro-1,7-phenanthroline (ICI 74,917), and disodium cromoglycate this selectivity was remarkable; to produce 50% inhibition of enzyme activity, a 10-100-fold lower concentration of these agents was required with the former enzyme than with the latter. Compound 48/80, on the other hand, showed high selectivity as an inhibitor of the cyclic AMP-specific, low-Km phosphodiesterase. Among the reference phosphodiesterase inhibitors examined, theophylline, 3-isobutyl-1-methylxanthine, and papaverine inhibited both low-Km enzymes to a comparable degree, whereas 4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone (Ro 20-1724) was pronouncedly more active toward the cyclic AMP-specific enzyme. Most compounds examined also inhibited the activity of a high-Km phosphodiesterase which hydrolyzes cyclic AMP and cyclic GMP at comparable rates. Pronounced inhibitory potency was recorded for Dicumarol, doxantrazole, compound 48/80, and papaverine, whereas M & B 22,948 was only slightly effective with this enzyme.

Note:
ACKNOWLEDGMENTS We thank our colleagues at Draco for valuable discussions, and Drs. H. Schüller and H. Henriksson, who kindly provided human lung tissue specimens.

Submitted on May 4, 1976
Accepted on August 23, 1976




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Trivedi, V. A. Narkar, T. Hussain, and M. F. Lokhandwala
Dopamine recruits D1A receptors to Na-K-ATPase-rich caveolar plasma membranes in rat renal proximal tubules
Am J Physiol Renal Physiol, November 1, 2004; 287(5): F921 - F931.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1977 by the American Society for Pharmacology and Experimental Therapeutics